With each passing day, the Wuhan Coronavirus continues to spread like wildfire not just in China, but also several parts of the globe. Today it has infected over 78,000 people and has killed over 2700.
The fear for contracting the COVID-19 has resulted in major global events like the Mobile World Congress to get cancelled with various participants hesitant to step out of the country. And this fear also surrounds the upcoming 2020 Tokyo Olympics.
Need for a vaccine to stop this novel coronavirus is needed today more than ever. And it looks like we might not have to wait for long after all.
Scientists since the news of the outbreak have been working on a vaccine to combat and prevent people from the novel coronavirus and now a company called Moderna has announced that it has finally developed a coronavirus vaccine that will soon be ready for human testing.
First reported by the Wall Street Journal, the vaccine has already been provided to the US governments at the National Institute of Allergy and Infectious Diseases in Bethesda. It reveals that there are two doses to the vaccine, and the twin doses are designed for an adult to save him/her against infection.
Looking at the pace in which the research is moving a final product for human trial could be ready as early as July this year. While it sure feels like a lot of time, you need to understand that the rate at which the research for the vaccine is moving at, is unprecedented, to say the least.
Researchers need to make sure a number of things before they decide to inject the vaccine into a human. Not only should it work as we intend it to, but it should also protect the person from contracting the virus for a considerable amount of time.
Moreover, it shouldn’t come with any adverse side effects or cause severe harm to a person’s body. Researchers will also have to look at how it pairs with existing common medication that people consume.